Key result
The diagnosis of malignant fibrous histiocytoma should be restricted to pleomorphic sarcomas lacking a specific line of differentiation, often requiring immunohistochemistry or electron microscopy.
Answers are grounded in this paper and cite their sources.
Highlights the evolving diagnostic criteria and classification of malignant fibrous histiocytoma, emphasizing the need for immunohistochemistry or electron microscopy to identify lines of differentiation.
The precise nature and diagnostic concept of malignant fibrous histiocytoma (MFH) has been debated for years. Currently, a histiocytic lineage of the tumor cells is no longer favored. The nomenclature and classification of MFH and its subtypes have also been changed. The MFH pattern, especially that of storiform-pleomorphic variant, is viewed as a morphologic pattern shared by a number of sarcomas as well as by other nonsarcomas. Therefore, a diagnosis of MFH based solely on morphology is no longer acceptable and identification of a line of differentiation should be sought. A diagnosis of MFH should be made only for pleomorphic sarcomas in which no specific line of differentiation is discerned. Precise categorization of MFH-like tumors may require thorough sampling of the tumor and judicious use of immunohistochemistry and/or electron microscopy. Familiarity with the current terminology and classification of MFH and its subtypes is of paramount significance in the modern practice of pathology.
No takes yet. Share an insight, caveat, or question.
Al‐Agha et al. (2008) conducted a review in Malignant fibrous histiocytoma. The diagnosis of malignant fibrous histiocytoma should be restricted to pleomorphic sarcomas lacking a specific line of differentiation, often requiring immunohistochemistry or electron microscopy.
Synapse has enriched 10 related papers. Consider them for comparative context: